top of page

Pfizer: Early Trial Data Suggests Updated COVID-19 Booster Protects Against Omicron

Writer's picture: Aryaman Sinha Aryaman Sinha


Pfizer and its partner BioNTech reported on Thursday that the shots elicit more antibodies that fight the omicron subvariants BA.4 and BA.5 than the original coronavirus shot one week after the shots were administered. The shot was well tolerated with positive safety data similar to that of the original vaccine, according to Pfizer. Awesome!



Photo Credit: Markus Spiske

7 views0 comments

Comments


Thanks for submitting!

Stay updated on the latest good newz!

GoodNewzUniversal brings the top positive news about the world, daily. No matter what happens, there is always going to be good news all over the world. This website has assembled it, just for you.

    © 2023 BY ARYAMAN SINHA

    bottom of page